Latest news
MSTR Up 5%, Targets $105 Resistance For the Third Time: What's Happening? - BenzingaBenzinga · Fri, 07 Aug 2026 16:46:31 GMTTwo Rejections, Messy Process: Replimune Finally Secures FDA Approval for Skin Cancer Treatment - BenzingaBenzinga · Fri, 07 Aug 2026 11:49:41 GMTTrump Tries Again on Birthright Citizenship With New Orders— This Time It Targets 'Birth Tourism' - BenzingaBenzinga · Fri, 07 Aug 2026 07:04:59 GMTTrump Rejects DOJ's Findings, Kelly Warns Democrats, Warren Backs Trump on Debt Ceiling and More - BenzingaBenzinga · Sun, 02 Aug 2026 09:00:22 GMTTrump Rejects His Own DOJ's Findings, Says 'Pure Vandalism'—Not Faulty Installation—Damaged Lincoln Memor - BenzingaBenzinga · Sun, 02 Aug 2026 02:25:48 GMTOutlook Therapeutics Targets Multibillion Dollar Ophthalmology Market With New Drug After FDA Rejection - BenzingaBenzinga · Mon, 27 Jul 2026 14:13:30 GMT